CNE000001JJ6
CNE000001JJ6
HUAPONT LIFESCIENCES
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 9.05B EUR | 7.78B EUR | 10.35B EUR |
Enterprise Value | 17.71B EUR | 12.22B EUR | 14.42B EUR |
Valuation Multiples | |||
Trailing P/E | 13.85x | 12.45x | 16.06x |
Forward P/E | -- | -- | -- |
Price to Sales | 0.79x | 0.68x | 0.93x |
Price to Book | 0.89x | 0.77x | 1x |
EV/Revenue | 1.54x | 1.07x | 1.29x |
EV/EBITDA | 7.4x | 7.45x | 9.41x |
Price to FCF (P/FCF) | 8.51x | 5.03x | 9.63x |
EV/FCF | 16.65x | 7.9x | 13.42x |
FCF Yield | 11.75% | 19.88% | 10.38% |